Forget Software: Smart Money Bets on Autonomous Weapons
Investors are pouring into autonomous weapons and defense tech, signaling a shift from software plays to hardware-dri...
What Age Should You Plan For Retirement
Planning for retirement at the right age is crucial for financial security. Discover how to choose the best age to start your retirement plan.
26,113 articles
LBank Launches Enhanced Earn with Higher TRX Yields
LBank unveils an upgraded TRX Earn program featuring tiered yields and new Locked Earn products, delivering up to 11%...
Elon Musk Trillionaire Moment, Tesla Stocks Slump 2026
Rising buzz that Elon Musk could reach trillionaire status clashes with Tesla's 2026 stock slump. This report breaks ...
Ripple Price Analysis: Seller Exhaustion Signals Recovery
Ripple price action shows early signs of seller exhaustion near a critical support, setting the stage for a potential...
Ripple Ethereum Jump as Iran Truce Triggers Bitcoin Rally
Crypto markets surged as talk of a potential Iran truce revived risk appetite. Ripple and Ethereum led gains, with Bi...
Crypto News: June US-IRAN Deal Shakes Global Markets
A fast-tracked June US-IRAN deal rattles risk assets while BTC holds near $66,000 and ETH begins to show life. FTX cl...
Shiba Metric Plunges 5-Year, Traders Eye Potential Rally
Shiba Inu’s key on-chain metric has dropped to a five-year low, signaling caution but also a possible setup for a fut...
Arthur Hayes Adds More ETH Amid Backlash Over Hype, ZEC, WLD
Former BitMEX CEO Arthur Hayes appears to be adding more ETH as critics circle over recent token hype and sales. Look...
Oil Prices Fluctuate as Trump's Iran Deal Reopens Hormuz
Oil prices moved in a narrow range as investors weigh a potential U.S.-Iran deal that could reopen the Strait of Horm...
Ethereum Price Analysis: Sellers Hold Ground, Rebound Fades
Sellers are reasserting control as Ethereum’s relief rally fades, keeping prices range-bound near critical levels and...
Strive CEO: Sharp STRC, SATA Selloff Traced to Leverage
Strive's CEO says recent STRC and SATA declines were driven by leverage-induced liquidations rather than weakening fu...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status